BlackRock Maintains Significant Stake in Arvinas, Inc.
Ticker: ARVN · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1655759
| Field | Detail |
|---|---|
| Company | Arvinas, Inc. (ARVN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns Arvinas stock, good sign for stability.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership of Arvinas, Inc. Common Stock as of December 31, 2023. This filing indicates that BlackRock, a major institutional investor, continues to hold a significant stake in Arvinas, Inc., signaling ongoing confidence in the pharmaceutical company. For investors, this means a large, influential fund manager sees value in Arvinas, which could be a positive indicator for the stock's stability and future prospects.
Why It Matters
This filing shows a major institutional investor, BlackRock, continues to hold Arvinas stock, which can be seen as a vote of confidence in the company's long-term potential.
Risk Assessment
Risk Level: low — This filing is routine and indicates a major institutional investor's continued stake, which generally reduces perceived risk.
Analyst Insight
An investor should note BlackRock's continued holding as a sign of institutional confidence, but also conduct their own due diligence on Arvinas, Inc.'s fundamentals and future prospects.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Arvinas, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the date the SC 13G/A was filed
Forward-Looking Statements
- BlackRock will likely maintain its significant stake in Arvinas, Inc. throughout 2024, barring any major negative developments for Arvinas. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the 'Name of Issuer' in this filing?
The 'Name of Issuer' is Arvinas, Inc., a pharmaceutical preparations company with CIK 0001655759.
Who is the 'FILED BY' entity in this document?
The 'FILED BY' entity is BlackRock Inc., a security brokers, dealers & flotation company with CIK 0001364742.
What is the CUSIP Number for the securities reported?
The CUSIP Number for the Common Stock of Arvinas, Inc. is 04335A105.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding ARVINAS, INC. (ARVN).